8/10/2019 14068598691

1/18

General Information Booklet of the

19thGroup Training Course for African Countries

Infectious Diseases: Clinical and Laboratory Diagnosis

!ICCI"

October 14 t h to November 13 t h 2014

#rgani$ed by

Suez Canal University

Ismailia Ey!t

In Collaboration %ith

Ey!tian "ency o# $artnershi! #or %evelo!ment

Ey!tian &inistry o# 'orein "##airs

(a!an International Coo!eration "ency )(IC"*

(uly 2014

8/10/2019 14068598691

2/18

CONTENTS

PREFACE... 1

I. COURSE OUTLINE. 1Duration ... 2

Number of participants 2

Training Needs .2

Purpose 2

Objecties 2

!et"odo#og$ %Curricu#um and t"e course &genda %

Training Institution .. '

Certificate .. '

II. CONDITION OF THE APPLICATION

1. (ua#ification of &pp#icants .. '

2. Procedure for app#ication . '

III. ALLOWANCES & EXPENSES.. )

I*. ACCOMMODATION )

*. REGULATIONS.. )

*I. RECREATIONAL ACTIVITY .... +

*II. PRE-DEPARTURE INSTRUCTIONS... +

*III. CORRESPONDENCE +

I,. ANNEXI -orm of &pp#ication

,. ANNEX II Time Tab#e of t"e 1/t"ICCI 11

,I. ANNEX III 0ist of participants of 1/t"ICCI 1+

8/10/2019 14068598691

3/18

PREFACE

t"oug" t"e &frican econom$ is getting "ea#t"$ due to rising oerseas inestment fo##oingt"e conc#usion of regiona# disputes and soaring prices for minera# resources 3et t"e #ies of

peop#e #iing in &frica continue to be t"reatened b$ a range of factors inc#uding substantia##$rising oi# and food prices around t"e g#obe disputes and famine around t"e &frican continentinfectious diseases suc" as 4I*5&IDS ma#aria and tubercu#osis and t"e prob#ems of cumu#atie

debt and #o sc"oo# attendance rates.

6apan "as or7ed to support &fricas sustainab#e grot" since t"e 1889s. &t t"e To7$oInternationa# Conference on &frican Dee#opment TIC&D I* "e#d in 3o7o"ama 6apan in 299/t"e 6apanese goernment made an internationa# commitment to doub#e its aid to &frica b$ 2912.To fu#fi## t"is commitment priorit$ issues and efforts ere set. One of t"em is to ensuring "umansecurit$. 6IC& aspires to foster freedom from deficiencies suc" as poert$ staration #ac7 ofeducation and inade:uate access to "ea#t" and medica# serices. -or peace and securit$ 6IC&fosters freedom from fear proo7ed b$ conf#icts terrorism crime "uman rig"ts io#ationsinfectious disease outbrea7s enironmenta# destruction economic crises and disasters.

so to fu#fi## t"is commitment 6IC& carries out actiities focused on supporting &frica toac"iee se#f;re#iance and t"e gap beteen t"e efforts esdiscussions i## dee#op t"eir researc" and manageria# s7i##s and #eaders"ip :ua#ities.

I. COURSE OUTLINE:

1) Cour! T"#$!:

"Infectious Diseases: Clinical and Laboratory Diagnosis (ICCI)

%) Dur#"o'?

-rom October 1't"to 1%t"Noember 291'.

() I'"#!* Cou'#r"!:

T"e @oernments of t"e fo##oing countries i## be inited to app#$ b$ nominating t"eir

app#icants for t"e course:Burundi, Democratic Republic of Congo, Ethiopia, Eritrea, Kenya,

Malawi, Rwanda, Sudan, South Sudan, Tanania, and !ganda.

1

8/10/2019 14068598691

4/18

+) Nu,!roPr#"/"0'#:

T"e tota# number of participants i## be tent$ A29B seenteen A1B from &frican countries and t"ree

A%B from Eg$pt.

) Tr"'"'2 N!!*?

T"e ro#e of infectious diseases in t"reatening t"e "uman #ife "as been re;e

8/10/2019 14068598691

5/18

6) M!#7o*o$o28:

T"e course i## be conducted in t"e form of 0ectures A0B Practices APB -ie#d;trips A-B @roupStudies A@B Gor7 S"op AGB J sma## group discussions.

9) Curr"/u$u, '* #7! /our! 2!'*:

T"e curricu#um sc"eme i## inc#ude?I. 0ECT=ES?

1B io;ris7 iosafet$ and 0ab &c:uired Infections2B -undamenta# Immuno#og$

%B Immunit$ to *iruses acteria J Parasites'B Parasitic Infestations)B *ira# infections+B acteria# infectionsB Princip#es and interpretation of some important Immuno#ogica# Tec"ni:ues/B Introduction to !o#ecu#ar io#og$8B (ua#it$ contro# and :ua#it$ assurance

II. P&CTIC&0 SESSIONS?

Immuno#ogica# Tec"ni:ues.1 Neutrop"i# p"agoc$tosis.

2 Comp#ement assa$ b$ ID.

3 Immunob#ot? confirmator$ tec"ni:ues.

4 Immunof#uorescence detection of auto;antibodies.

5 apid testing for 4I* J 4s&g.

6 Immunofi

8/10/2019 14068598691

6/18

T"ese intensie or7s"ops i## "e#p participants grasping essentia#s for dee#opment of aresearc" protoco#. T"e fo##oing topics i## be emp"asiFed in t"e or7s"op? esearc" designSources of bias in medica# researc" !easurements J t$pes of error Inter;obserer J Intra;obserer disagreement Data management 4o to use a simp#e computer pac7age for statistica#ana#$sis of data.

The aboe curriculum may be #ub$ect to #ome change#%

1;) M"' Tr"'"'2 I'#"#u#"o'?

T"e Scientific Center for 4uman Dee#opment SueF Cana# =niersit$ ASC4D5SC=B is t"einstitute responsib#e for conducting t"e program. SC= as estab#is"ed in 18+ as goernmenta#uniersit$ t"e basic p"i#osop"$ of SueF Cana# =niersit$ is t"at t"e goa# of true education must

be to produce $oung adu#ts "o are bot" :ua#ified and eager to render serice to t"e communit$and t"e SC= is t"us t"e first communit$;oriented educationa# institution in Eg$pt. T"e programi## be conducted in t"e faci#ities of t"e facu#t$ of medicine SueF Cana# =niersit$ A-O!5SC=Band t"e e

8/10/2019 14068598691

7/18

2.% T"e @oernment of t"e &rab epub#ic of Eg$pt i## inform t"e nominating @oernment t"roug"dip#omatic c"anne#s "et"er or not t"e app#icantAsB is5are accepted to t"e Course not #ater t"an t"irt$A%9B da$s before t"e commencement of t"e Course.

)

8/10/2019 14068598691

8/18

() A00$"/#"o' D!*$"'!:

D!*$"'! or !'*"'2 00$"/#"o' " 1#7 o S!0#!,!r= %;1+.N.>.: H'*?r"##!' A00$"/#"o' ?"$$ 'o# ! //!0#!*. O'$8 /o,0u#!r #80!* 00$"/#"o' ?"$$ !

!@,"'!*. A o# /o08 o #7! GI ?"#7 #7! 00$"/#"o' or, /' ! ou'* o' 7##0:???.5"/-

#/#0./o, or r!Bu!#!* *"r!/#$8 #7rou27 !-,"$.

III. ALLOWANCES & EXPENSES

T"e fo##oing a##oances and e

8/10/2019 14068598691

9/18

VI. RECREATIONAL ACTIVITIES

; T"roug" t"e duration of t"e course arrangements i## be made to sc"edu#e recreationa# actiities andisits to P$ramids and Sp"in

8/10/2019 14068598691

10/18

7 #

"NNE? I'O-& O' NO&IN"/ION

For the 19thCourse:

"Infectious Diseases: Updates in Laboratory Diagnosis"(ICCI)

October 14thto November 13th. 2014

$art I(To be completed by nominee. Please print or type) (Surname) (First name)

1. Name:------------------- ------------------------

2. . e!: "ale Female

#. Title $ %e&ree:

'. %ate Place o birth:------------------------------------------------------

*. +ddress or correspondence:---------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

,. Number o Passport::

-mail :-----------------------------------------------------------------------------

. Fa!: --------------------------------------------------------------------------------

/. Tel: ---------------------------------------------------------------------------------

N.B. Please type a clear phone, fax number, E-mail and participants address for arapid and efficient correspondence bet!een the course or"ani#ers, the E"yptian$iplomatic %ission and the selected participant for attendin" the course.

9. "arital tatus :---------------------------------------------------------------------

10. Nationality: -----------------------------------------------------------------------

11. Name +ddress o person to be notiy in case o emer&ency:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------

Tel:: --------------------------------------------------------------------------------

Fa! :: --------------------------------------------------------------------------------

-mail : ---------------------------------------------------------------------------

/

8/10/2019 14068598691

11/18

Please send a copy to the Course Director.raduate and esearch tudies3

ue4 Canal 5ni6ersity3TCTP Pro&ram %irectorate3

7smail ia3 8PT . Tel: 20-,'-# 2#2'*,

"obile: 20-100-#//1199 Fa!: 20-,'-#222##

-"ail: amicci;hotmail.com Cc to: ino;

8/10/2019 14068598691

12/18

1'. T7! EXPERIENCES...................................................................................................................................................................................

$art II

(o be completed by nominee)

73 >>>>>>>>>>>>>>>>>>> o ........ ......... ...>>>>..

(Name of nominee) (*ountry)

7 Certi y that the statement made by me in this orm is true3 complete and

correct to the best o my belie3 and underta?e to ol lo@ al l the re&ulationsincluded in the eneral 7normation o the Course.

>>>>>>>......................3 201'

(Si"nature of nominee- $ate)

19

8/10/2019 14068598691

13/18

$"-/ III

(o be completed by an authori#ed official of the nominatin" +oernment)

1 O''ICI"@ NO&IN"/ION

=n behal o the o6ernment o .....>>>>>>>>>>>>>>.3 7 certi y that:

+. 7 ha6e e!amined the educational3 proessional or other cert i icates Auoted bythe nominee in $art I o this orm and 7 am satisied that they are authenticand relate to the nominee.

B. 7 ha6e e!amined the medical cert i icate produced by the nominee @hichstates that he is medically i t and ree rom any inectious disease and @ithre&ard to his physical and mental histor y there is no reason to suppose t hatthe nominee is other than i t to underta?e the >>>>>>>>>>>>>>>>.>>>>..>>>..

i&nature:...................

Position:....................

%ate:. . . . . . . . . . . . . . . . . . . . . . . . . .

=icial tamp

=r&ani4ation:..............>>>>>>>>>>>>>

2. CO--ES$ON%ENCE : (Please indicates person and address to !hich any

correspondence re"ardin" this from can be addressed.)

. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . .. . .

>>>>>.... . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . .

11

8/10/2019 14068598691

14/18

18thGroup Training Course for African Countries

&Infectious Diseases: 'pdates in Laboratory Diagnosis !ICCI"

N o v e m b e r 1 8 t h to %ecember 18 t h 2013

F"r# W!!

Su'*8 14.11.%;1(

Or2'"!rCour! or"!'##"o' & M!!#"'2 #7! 0r#"/"0'#11:;;-1%:;;

Mo'*816.11.%;1(

Pro. A. Mo#7

SCU - E280#I'#ro*u/#"o' #o Ar"/ $'2u2!6:(;-9:;;

Dr. . ur"

EMRI - !'8

>"o!/ur"#8 & >"o!#7"/9:;;-1%:;;

Co!! >r!1%:;;-1%:(;

Co'/!0# o >"o!#8 & >"o!/ur"#81%:(;-1(:(;

>"o!#8 R" A!,!'#= R" M'2!,!'#= & R"

Co,,u'"/#"o'

1(:(;-1:(;

O//u0#"o'$ H!$#7 & S!#81:(;-14:;;

Tu!*8 19.11.%;1(

Dr. . ur"

EMRI - !'8

I'!/#"o' Pr!!'#"o' & Co'#ro$6:(;-9:+

W#! M'2!,!'# Pro2r,1;:;;-11:(;

Lor#or8 E,!r2!'/8 & I'/"*!'# R!0o'! Pro2r,11:(;-1%:(;

Opening Ceremony1(:;;-1:;; W!*'!*8 %;.11.%;1(

Pro. A. Mo#7

SCU - E280#I'#ro*u/#"o' #o Ar"/ $'2u2!6:(;-9:;;

Dr. . ur"

EMRI - !'8

M$r" T7!or8 & Pr/#"/$9:;;-1%:;;

Co!! >r!1%:;;-1%:(;

Pr#"/"0'# Pr!!'##"o' 1)1%:(;-1(:(;

L"7,'"" T7!or8 & Pr/#"/$1(:(;-13:(;

T7ur*8 %1.11.%;1(

Dr. . ur"

EMRI - !'8

Pr#"/"0'# Pr!!'##"o' %)6:(;-9:(;

Cour! E$u#"o'9:(;-1;:;;

F"$r"" T7!or8 & Pr/#"/$1;:;;-1(:;;

Co!! >r!1(:;;-1(:(;

Dr. N. E$ N!,r

SCU - E280#

S/7"#oo,"" E0"*!,"o$o28= C$"'"/$ D"2'o"= &

M'2!,!'#

1(:(;-1:;;

Dr. M. S$,

SCU - E280#S/7"#oo,"" Lor#or8 D"2'o"1:;;-13:(;

&riday ''%((%')(* &ree time

Saturday '*%((%')(* &ield Trip in +#mailia

S!/o'* W!!

Su'*8 %+.11.%;1(

Pr#"/"0'# Pr!!'##"o' ()6:(;-9:(;

Dr. R. Mou#

SCU - E280#C!$$ M!*"#!* I,,u'"#89:(;-11:;;

Pro. F. Gour'

SCU E280#S!#8 "' >$oo* Tr'u"o'11:;;-1%:(;

12

8/10/2019 14068598691

15/18

Co!! >r!1%:(;-1(:;;

S#u*8 V""# #o N#"o'$ >$oo* >'1(:;;-1:;;

Mo'*8 %.11.%;1(

Pro. Mo#7I'#ro*u/#"o' #o Ar"/ $'2u2!;6:(;-9:;;

Pr#"/"0'# Pr!!'##"o' +)9:;;-1;:;;

Dr. S. You'!I''#! I,,u'"#81;:;;-11:;;

Dr. M. S7r?8

SCU E280#N!u#ro07"$ P72o/8#o"11:;;-1(:;;

Co!! >r!1(:;;-1(:(;

Dr. N. E$ N!,rV"r$ H!0#"#"1(:(;-1:(;

Pro. E. A*u$$7

SCU E280#

Mo$!/u$r >"o$o28 T!/7'"Bu! or D"2'o" o I'!/#"ou D"!!1:(;-14:;;

Tu!*8 %3.11.%;1(

Pr#"/"0'# Pr!!'##"o' )6:(;-9:(;

Dr. A. H7"7

SCU E280#

HCV RNA PCR: E@#r/#"o'9:(;-1%:(;

Co!! >r!1%:(;-1(:;;

HCV RNA PCR: A,0$""/#"o'1(:(;-1:(;

HCV RNA PCR: D!#!/#"o'1:(;-13:(;

W!*'!*8 %4.11.%;1(

Pro. Mo#7I'#ro*u/#"o' #o Ar"/ $'2u2!;6:(;-9:;;Dr. R. Mou#INNO-LIA9:;;-1%:;;

Co!! >r!1%:;;-1%:(;

Dr. S. You'!

SCU E280#CD+ A!,!'# 8 F$o? C8#o,!#r81%:(;-1:(;

T7ur*8 %6.11.%;1(

Cour! E$u#"o'6:(;-9:;;

Dr. R. E,*

SCU E280#A!,!'# o Co,0$!,!'# 8 RID9:;;-1;:(;

Dr. H. H'

SCU E280#I,,u'!-F"@#"o'1;:(;-1%:(;

Co!! >r!1%:(;-1(:;;

Dr. N. Yo7"7rICA - 0'

HIV E0"*!,"o$o28 "' 0'1(:;;-1+:;;

Dr. O,r F#7"F$o? C8#o,!#r8 A'$8"1+:;;-1:;;

Fr"*8 %911& S#ur*8 (;11%;1( F"!$* Tr"0 #o C"ro

1%

8/10/2019 14068598691

16/18

T7"r* W!!

Su'*8 ;1.1%.%;1(

Pr#"/"0'# Pr!!'##"o' 3);6:(;-9:(;

Dr. R. Mou#

SCU E280#

Mo$!/u$r >!* V"r$ V//"'!9:(;-1;:(;

Dr. N. Yo7"7r

ICA - 0'

>$oo* >'"'2 "' 0'1;:(;-11:(;

Co!! >r!11:(;-1%:;;

R0"* D"2'o" o HIV & H>V11:(;-1:;;

Mo'*8 ;%.1%.%;1(

Pro. Mo#7

SCU E280#I'#ro*u/#"o' #o Ar"/ $'2u2!;6:(;-9:;;

Pro. H. F#78

SCU E280#

Ho? #o ?r"#! 2r'# 0ro0o$9:;;-1%:(;

Co!! >r!1%:(;-1(:;;

Wor"'2 "' ,$$ 2rou01(:;;-13:;;

Tu!*8 ;(.1%.%;1(

Pro. H. F#78

SCU E280#

R!!r/7 M!#7o*o$o28 Wor7o06:(;-11:(;

Co!! >r!11:(;-1%:;;

Wor"'2 "' ,$$ 2rou01%:(;-13:;;

W!*'!*8 ;+.1%.%;1(

I'#ro*u/#"o' #o Ar"/ $'2u2!;6:(;-9:;;

Dr. W. A,"'

SCU - E280#

DOT & DOT P$u9:;;-1;:;;

MDR1;:;;-11:;;

T> C$"'"/$ A0!/#11:;;:1%:;;

Co!! >r!1%:;;-1%:(;

Pro. G. H*"*8

SCU - E280#T>: W7# #7! P78"/"' S7ou$* 'o?1%:(;-1(:;;

Pro. A. H!"

SCU E280#I,,u'"#8 A2"'# >/#!r"1(:;;-1:;;

T7ur*8 ;.1%.%;1(

Cour! E$u#"o'6:(;-9:;;

Pro. S. Ho'8

D!' FOM

SCU E280#

L!*!r7"09:;;-1%:(;

Co!! >r!1%:(;-1(:;;

Wor"'2 "' S,$$ Grou01(:;;-13:;;

Fr"*8 & S#ur*8 3-41( F"!$* #r"0 #o A$!@'*r"

1'

8/10/2019 14068598691

17/18

Four#7 W!!

Su'*8 6.1%.%;1(

F"!$* Tr"0 #o M,our C7!# 7o0"#$;9:(;-1+:;;

Mo'*8 9.1%.%;1(

Pro. Mo#7SCU E280#

I'#ro*u/#"o' #o Ar"/ $'2u2!6:(;-9:;;

Pro. A. S*

SCU E280#A0o0#o" & I'!/#"o'9:;;-1;:(;

Dr. N. ,!$

SCU E280#H!,#o$o2"/$ C7'2! "' T> I'!/#"o'1;:(;-11:(;

Dr. S. T!,o#o

NH 0'So$u$! C8#o"'! R!/!0#or "' V"r$ I'!/#"o'11:(;-1%:(;

Co!! >r!1%:(;-1(:;;

Dr. L. M!#?$$8

SCU E280#Mo$!/u$r D"2'o#"/ "' T>1(:;;-1+:;;

Dr. M. H'T> D"2'o": r!11:;;-11:(;

Dr. M. H'T> D"2'o": r!11:;;-11:(;

Dr. A. ,$So$u$! CD(; 8 ELISA11:(;-1+:;;

Dr. A. ,$So$u$! IL-%R 8 ELISA1+:;;-13:(;

T7ur*8 1%.1%.%;1(

Cour! E$u#"o'6:(;-9:;;

Dr. M. H'8

SCU E280#

8/10/2019 14068598691

18/18

F"#7 W!!

Su'*8 1.1%.%;1(

Dr. M. H'8

SCU E280#

Tr"'"'2 Tr'!r9:(;-1%:;;

Co!! >r!1%:;;-1%:(;

Wor"'2 "' S,$$ Grou01%:(;-13:;; Mo'*8 13.1%.%;1(

C$"'"/$ P#7o$o28 D!0r#,!'# A''u$ Co'!r!'/! D8 1)9:(;-13:;;

Tu!*8 14.1%.%;1(

C$"'"/$ P#7o$o28 D!0r#,!'# A''u$ Co'!r!'/! D8 %)9:(;-1%:(;

FI!L CU#$% %&!LU!'I

CL$I C%#%*

DI$'#I+U'I F C%#'IFIC!'%$

D%P!#'U#%

1%:(;-1:;;